The debate over America’s drug-pricing system is built on myths
It’s time to face the reality about how medicines are made, and what cutting drug prices could mean for research and development of new ones.
Related Articles
Balancing the Scales: Real-Life Fellows’ Perspectives on Navigating Work-Life Balance in Oncology Training and Beyond
Drs. Noha Soror and Fionnuala Crowley outline challenges of and strategies for maintaining work-life balance during oncology fellowship, including tips for parents of young children.
Cell and Gene Therapies: THE LOGISTICS
Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson’s end-to-end platform built to address…
Wimbledon 2025: Jannik Sinner says progress ‘not a win’ after Grigor Dimitrov injury
Jannik Sinner says he cannot accept his progress to the Wimbledon quarter-finals “as a win” following Grigor Dimitrov’s injury heartbreak.
Marketing Disguised as Science Embarrasses Everyone Involved
A prominent medical journal embarrrasses itself by publishing a flawed study from the American Board of Internal Medicine. Critical appraisal lessons are obvious.
Changing the Blood Diagnostic Industry With Dena Marrinucci
Dena Marrinucci, PhD, co-founder and COO of Truvian Health, joins my Healthcare Unfiltered podcast to discuss her mission to transform blood diagnostics thro…
Changing the Blood Diagnostic Industry With Dena Marrinucci
Podcast Episode · Healthcare Unfiltered · 06/17/2025 · 45m
Ryght AI Announces New Partnerships and Funding to Digitize Every Clinical Trial Site with AI
Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, today announced several new academic medical center (AMC) partnerships and…
Part 2: The Keto Heart Study
Last week, we explored the KETO-CTA study, which investigated the effects of the ketogenic diet on coronary plaque formation in Lean Mass Hyper-Responders (L…